The early use of ASPIRIN in COVID-19 patients

in #covid19last year

image.png

The early use of aspirin in covid-19 patients, which also has the effects of inhibiting virus replication, anti-platelet aggregation, anti-inflammatory and anti-lung injury, is expected to reduce the incidence of severe and critical patients, shorten the length of hospital duration and reduce the incidence of cardiovascular complications.

Source:
Protective Effect of Aspirin on COVID-19 Patients (PEAC)